Source link : https://www.newshealth.biz/health-news/ctdna-testing-shows-promise-for-influencing-colorectal-cancer-treatment/
SAN FRANCISCO — Circulating tumor DNA (ctDNA) measurements showed promise for identifying patients with early colorectal cancer (CRC) most likely to benefit from adjuvant therapy, analyses of two large clinical trials suggested. Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received adjuvant […]
Author : News Health
Publish date : 2025-01-27 19:41:51
Copyright for syndicated content belongs to the linked Source.
Categories